Literature DB >> 10720521

Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients.

C Goerke1, K Kraning, M Stern, G Döring, K Botzenhart, C Wolz.   

Abstract

The molecular epidemiology of Staphylococcus aureus nasal commensal strains and community-acquired infecting strains was assessed by comparison of prevalence, persistence, transmission rate, and clonal distribution of S. aureus in families with and without cystic fibrosis (CF) patients. Isolates were typed by pulsed-field gel electrophoresis. CF patients without antibiotic treatment had a significantly higher nasal prevalence (66%) of S. aureus than did treated patients (29%; P<.001) or healthy controls (32%; P<.001), suggesting that persons with CF have a higher susceptibility to this organism. Strain transmission was frequent within both CF (55%) and non-CF (62%) families. After 3 and 19 months, 57% and 21%, respectively, of all persons still harbored the same S. aureus strain. Most of the isolates (78%) belonged to 8 of 38 genome types common in CF patients and in healthy persons. The predominant occurrence of a limited number of S. aureus clones within the community suggests evolutionary mechanisms for the selection of certain strains without an obvious association with disease.

Entities:  

Mesh:

Year:  2000        PMID: 10720521     DOI: 10.1086/315331

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Health service careers for people with cystic fibrosis.

Authors:  Sarah Walters
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus.

Authors:  Christiane Goerke; Johanna Köller; Christiane Wolz
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice.

Authors:  Bruno González-Zorn; Jose P M Senna; Laurence Fiette; Spencer Shorte; Aurélie Testard; Michel Chignard; Patrice Courvalin; Catherine Grillot-Courvalin
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.

Authors:  D Worlitzsch; H Kaygin; A Steinhuber; A Dalhoff; K Botzenhart; G Döring
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

6.  Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans.

Authors:  Marc Burian; Christiane Wolz; Christiane Goerke
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

Review 7.  Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.

Authors:  Maria E Møller; Mikkel C Alanin; Christian Grønhøj; Kasper Aanæs; Niels Høiby; Christian von Buchwald
Journal:  Am J Rhinol Allergy       Date:  2017-09-01       Impact factor: 2.467

8.  Superantigen types in Staphylococcus aureus isolated from patients with cystic fibrosis.

Authors:  J Bania; A Dabrowska; B Rózalska; B Sadowska; M Wieckowska-Szakiel; K Korzekwa; A Zarczyńska; J Bystroń; J Chrzanowska; J Molenda
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 9.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study.

Authors:  Barbara C Kahl; Angelika Duebbers; Gabriele Lubritz; Johannes Haeberle; Hans G Koch; Barbara Ritzerfeld; Marion Reilly; Erik Harms; Richard A Proctor; Mathias Herrmann; Georg Peters
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.